. Author manuscript; available in PMC: 2017 Jul 1.

Published in final edited form as: JAMA Oncol. 2016 Jul 1;2(7):964–965. doi: 10.1001/jamaoncol.2016.0350

Table 1.

Sample Characteristics by Treatment Group

	No Chemo (n=92)	Chemo/No ANTHR (n=74)	Chemo/ANTHR (n=24)	Total (n=190)
Age^*, years mean (SD), min-max	53.7 (7.4) 34–66	50.1 (7.9), 32–66	49.9 (11.0), 31–65	51.8 (8.3), 31–66
White, n (%)	76 (83%)	56 (76%)	19 (79%)	151 (79%)
Education (College or more), n (%)	76 (83%)	59 (80%)	21 (88%)	156 (82%)
WTAR IQ mean (SD), min-max	115.1 (8.6), 89–126	112.6 (10.1), 81–125	116.4 (6.3), 105–126	114.3 (9.1), 81–126
Disease Stage at Diagnosis^* n 0, I, II, III (%)	25 (27%) 57 (62%) 10 (11%) 0 (0%)	0 (0%) 28 (38%) 37 (50%) 9 (12%)	0 (0%) 3 (13%) 12 (50%) 9 (38%)	25 (13%) 88 (46%) 59 (31%) 18 (9%)
Chemo Only^*, n (%)	0 (0%)	17 (23%)	3 (13%)	20 (11%)
Radiation Only^*, n (%)	64 (70%)	0 (0%)	0 (0%)	64 (34%)
fBoth Chemo and Radiation^*, n (%)	0 (0%)	57 (77%)	21 (88%)	78 (41%)
Received Endocrine Therapy Ever (%)	59 (66%)	58 (79%)	15 (63%)	132 (71%)
Post-menopausal at BL, n (%)	55 (60%)	35 (47%)	11 (46%)	101 (53%)

p<.05 group differences;

WTAR = Wechsler Test of Adult Reading